Last reviewed · How we verify
NCT07326423: MITA-RCT
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With Autism
NA trial testing Mental Imagery Therapy for Autism (MITA) in ASD in 60 participants. Enrolling by invitation.
31 December 2026
Quick facts
| Lead sponsor | ImagiRation, LLC |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2021 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Mental Imagery Therapy for Autism (MITA)
- General executive function
Conditions studied
- ASD — all drugs for ASD →
Sponsor
ImagiRation, LLC
Who can join
Adults 2 to 5, any sex, with ASD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mental Imagery Therapy for Autism (MITA) is a highly innovative adaptive language therapy application for children with autism. MITA exercises are limitless in variations, therefore avoiding routinization. Each activity is dynamic, quickly adjusting to the child's exact ability level. All activities are disguised as games that engage children. A 3-year observational clinical study of 6,454 children with ASD demonstrated that children who engaged with MITA showed 2.2-fold greater language improvement than children with similar initial evaluations (p\<0.0001). This study explores MITA intervention in a randomized controlled trial of 60 children with ASD. Two- to five-year-old ASD children will be randomly assigned to one of two groups. The MITA group will supplement their conventional language therapy with MITA exercises. The control group will receive treatment-as-usual. The hypothesis is that the MITA group will show greater improvement in developmental milestones.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07326423
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ASD
Currently open trials in the same condition.
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07400484 — Differences in N-CAD Concentration and Brain Function Between Children With ASD and TD · recruiting
- NCT06670040 — Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder · NA · active not recruiting
- NCT04899544 — Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism · NA · recruiting
- NCT06012903 — Lower Urinary Tract Symptoms and School Functioning in Children · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07326423 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ImagiRation, LLC
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07326423.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing